Literature DB >> 11701705

Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients.

A Cachefo1, P Boucher, C Vidon, E Dusserre, F Diraison, M Beylot.   

Abstract

To determine the effect of hyperthyroidism on hepatic lipogenesis and cholesterol synthesis we measured these metabolic pathways (deuterated water method) in euthyroid and hyperthyroid subjects investigated in the postabsorptive state. Hyperthyroid patients had increased concentrations of glucose (P < 0.05), insulin (P < 0.05), nonesterified fatty acids (P < 0.01), and triglycerides (P < 0.05) and decreased levels of plasma cholesterol (P < 0.01). The contribution of hepatic lipogenesis to plasma triglycerides was largely increased in hyperthyroid subjects (23.0 +/- 1.8% vs. 7.5 +/- 0.2%; P < 0.001), whereas the fractional synthetic rate of cholesterol was moderately higher (5.0 +/- 0.8% vs. 3.3 +/- 0.2%; P < 0.05). mRNA levels of beta-hydroxy-beta-methyl glutaryl-coenzyme A reductase, measured in circulating mononuclear cells, were increased (P < 0.05), whereas those of low density lipoprotein (LDL) receptor and LDL receptor-related protein were unchanged. Sterol responsive element binding protein-1c mRNAs were undetectable in mononuclear cells from both groups of subjects. The large stimulation of hepatic lipogenesis in hyperthyroid patients is probably explained by both a direct action of thyroid hormones and the increase in insulin. It could contribute to their moderate rise in triglycerides levels. The decreased plasma cholesterol level is observed despite an enhanced synthetic rate and is thus related to an increased clearance rate. The lack of increased expression of LDL receptor and LDL receptor-related protein suggests that other receptors are implicated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701705     DOI: 10.1210/jcem.86.11.7981

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Pharmacological agents for nonalcoholic steatohepatitis.

Authors:  Maeva Guillaume; Vlad Ratziu
Journal:  Hepatol Int       Date:  2013-11-19       Impact factor: 6.047

2.  Free Triiodothyronine Is Associated With Hepatic Steatosis and Liver Stiffness in Euthyroid Chinese Adults With Non-Alcoholic Fatty Liver Disease.

Authors:  Wen Guo; Pei Qin; Xiao-Na Li; Juan Wu; Jing Lu; Wen-Fang Zhu; Qing-Qing Diao; Nian-Zhen Xu; Qun Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-12       Impact factor: 5.555

3.  Fatty acid metabolism and thyroid hormones.

Authors:  Naomi L Sayre; James D Lechleiter
Journal:  Curr Trends Endocinol       Date:  2012-01-01

4.  Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.

Authors:  Mark D Erion; Edward E Cable; Bruce R Ito; Hongjian Jiang; James M Fujitaki; Patricia D Finn; Bao-Hong Zhang; Jinzhao Hou; Serge H Boyer; Paul D van Poelje; David L Linemeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

5.  Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance.

Authors:  Miguel López; Luis Varela; María J Vázquez; Sergio Rodríguez-Cuenca; Carmen R González; Vidya R Velagapudi; Donald A Morgan; Erik Schoenmakers; Khristofor Agassandian; Ricardo Lage; Pablo Blanco Martínez de Morentin; Sulay Tovar; Rubén Nogueiras; David Carling; Christopher Lelliott; Rosalía Gallego; Matej Oresic; Krishna Chatterjee; Asish K Saha; Kamal Rahmouni; Carlos Diéguez; Antonio Vidal-Puig
Journal:  Nat Med       Date:  2010-08-29       Impact factor: 53.440

6.  Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.

Authors:  Melpomeni Peppa; Grigoria Betsi; George Dimitriadis
Journal:  J Lipids       Date:  2011-07-18

7.  Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance.

Authors:  Noelia Martínez-Sánchez; Patricia Seoane-Collazo; Cristina Contreras; Luis Varela; Joan Villarroya; Eva Rial-Pensado; Xabier Buqué; Igor Aurrekoetxea; Teresa C Delgado; Rafael Vázquez-Martínez; Ismael González-García; Juan Roa; Andrew J Whittle; Beatriz Gomez-Santos; Vidya Velagapudi; Y C Loraine Tung; Donald A Morgan; Peter J Voshol; Pablo B Martínez de Morentin; Tania López-González; Laura Liñares-Pose; Francisco Gonzalez; Krishna Chatterjee; Tomás Sobrino; Gema Medina-Gómez; Roger J Davis; Núria Casals; Matej Orešič; Anthony P Coll; Antonio Vidal-Puig; Jens Mittag; Manuel Tena-Sempere; María M Malagón; Carlos Diéguez; María Luz Martínez-Chantar; Patricia Aspichueta; Kamal Rahmouni; Rubén Nogueiras; Guadalupe Sabio; Francesc Villarroya; Miguel López
Journal:  Cell Metab       Date:  2017-07-05       Impact factor: 27.287

8.  Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study.

Authors:  Massimo Giusti; Lorenzo Mortara; Roberta Degrandi; Francesca Cecoli; Michele Mussap; Guido Rodriguez; Diego Ferone; Francesco Minuto
Journal:  Thyroid Res       Date:  2008-09-29

Review 9.  Similarities and Differences in the Peripheral Actions of Thyroid Hormones and Their Metabolites.

Authors:  Ruy A Louzada; Denise P Carvalho
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-19       Impact factor: 5.555

10.  Subclinical Hyperthyroidism: Status of the Cholesterol Transfers to HDL and Other Parameters Related to Lipoprotein Metabolism in Patients Submitted to Thyroidectomy for Thyroid Cancer.

Authors:  Gilbert A Sigal; Thauany M Tavoni; Bruna M O Silva; Roberto Khalil-Filho; Lenine G Brandão; Edmund C Baracat; Raul C Maranhão
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-02       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.